Health and Fitness Health and Fitness
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Impax Laboratories to Present at the UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Bond Labs Expands Resurrection(TM) into the Atlanta and Savannah Markets
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting
[ Wed, Sep 15th 2010 ] - Market Wire
Micromet to Present at the 2010 UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Medical Action Industries to Present in the 2010 UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Celgene Corporation to Present at the UBS 2010 Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
ArthroCare to Present at UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst Reports Results from Two Forodesine Oncology Studies
[ Wed, Sep 15th 2010 ] - Market Wire
SuperGen to Present at UBS Global Life Sciences Conference on September 22nd
[ Wed, Sep 15th 2010 ] - Market Wire
Four Rivers Announces Licensure of STT Technology .. Gain, Reduction of Overhead Costs and Future Prof
Tue, September 14, 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. lf of Shareholders of Acura Pharmaceuticals, Inc.
[ Tue, Sep 14th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. n On Behalf of Shareholders of ZymoGenetics, Inc.
[ Tue, Sep 14th 2010 ] - Market Wire
Micrus Announces Stockholder Approval of Merger Agreement with Johnson & Johnson
[ Tue, Sep 14th 2010 ] - Market Wire
Laboratory Corporation of America Holdings, Genzy .. ger Company, Wal-Mart Stores and Costco Wholesale
[ Tue, Sep 14th 2010 ] - Market Wire
Celera to Webcast Its Presentation at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
NPS Pharmaceuticals to Present at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alnylam to Webcast Presentation at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. entation at Stifel Nicolaus Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Law Office of Jonathan M. Stein, P.L. Investigate .. ary Duty by the Officers and Directors of Acura P
[ Tue, Sep 14th 2010 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
American Medical Systems Receives Favorable Ruling in Patent Lawsuit against Biolitec
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals participa en el Simposio Roche Colorado Corporation Peptide 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Aetna Wins Contract for Illinois Managed Medicaid Pilot Program
[ Tue, Sep 14th 2010 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of
[ Tue, Sep 14th 2010 ] - Market Wire
El tratamiento VIH de nico comprimido "Quad" de G .. in viral durante 48 semanas en estudio de fase II
[ Tue, Sep 14th 2010 ] - Market Wire
Genmab and Seattle Genetics Enter into Antibody-Drug Conjugate Research Collaboration
[ Tue, Sep 14th 2010 ] - Market Wire
Alexion to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence
[ Tue, Sep 14th 2010 ] - Market Wire
Guided Therapeutics Completes $3 Million Financing
[ Tue, Sep 14th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference

Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference


Published on 2010-09-14 05:12:39 - Market Wire
  Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, will present at the UBS Global Life Sciences Conference at the Grand Hyatt New York on Tuesday, September 21st at 4:30 p.m. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for 30 days following the conference.

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor® (doxepin), now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the companya™s web site at [ www.somaxon.com ].

Contributing Sources